Registry study for managing liver failure in China
Part of Digestive system clinical trials.
This is a study that collects real-world information about people with liver failure or “pre-liver failure.” It aims to help doctors choose the best management approach for patients like you and improve care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis that fits liver failure or pre-liver failure.
- You have severe weakness plus major stomach/intestine symptoms such as poor appetite, vomiting, or belly swelling.
- Your blood tests show liver irritation (higher ALT and/or AST) and worsening yellowing of the skin/eyes.
- Your blood clotting tests suggest a bleeding risk (either PTA is low or INR is high).
- Nothing major happened recently that would confuse your doctor’s ability to judge your current condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies fecal microbiota transplantation (a transfer of healthy gut bacteria from a donor) to help people with worsening liver failure. It may help by changing gut bacteria, which can affect complications like confusion, fluid buildup, infections, and kidney problems.
This study looks at people with very advanced liver problems to better understand what happens in real life. It may help doctors improve care for advanced cirrhosis and certain liver cancers.
This trial tests two different blood-filtering treatments for people with severe liver failure who are waiting for or unable to receive a liver transplant. It aims to see how these treatments affect blood clotting, inflammation, and organ function.
This study looks at people with liver cirrhosis who develop a sudden, severe worsening of their liver function (called acute-on-chronic liver failure). It aims to better understand this condition and how it affects patients in the intensive care unit, which could help improve care.
This study looks at new scoring systems to predict how patients with acute-on-chronic liver failure (a sudden worsening of long-term liver disease) will do. It may help doctors better understand and treat this condition.
This trial tests a new drug called AS1501 for people with acute-on-chronic liver failure (a sudden worsening of chronic liver disease). It aims to see if the drug can help improve liver function and reduce the need for a liver transplant. You may be eligible if you are in the early or middle stage of this condition and have a specific blood marker (high TRAIL level).
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.